Peptide therapy in Miami generally runs $200 to $600 per month for the medication itself, plus $300 to $800 up front for the consultation and baseline lab panel. At Nexsis BioHealth in Brickell, the structured GLP-1 route is priced as a complete 6-month program at $1,800, which includes physician supervision, labs, InBody composition tracking and medication management. Other peptide protocols are quoted after your consultation and bloodwork, because the drug, the pharmacy and the protocol length all move the number.
That is the short answer, and it is deliberately a range rather than a single figure. Anyone who gives you one flat price for peptide therapy before seeing your labs is pricing a product, not a treatment. What follows is the full breakdown: what each line item actually is, what makes one protocol three times the price of another, and how to tell a fair Miami quote from a bad one.
Peptide therapy is not one purchase. It is four, and clinics differ enormously in which ones they bundle and which ones they bill separately. Understanding the four lines is the difference between comparing quotes and guessing.
The consultation. A physician visit to review your history, current medications, prior hormone or peptide use, and what you are actually trying to change. In Miami this typically runs $150 to $350 as a standalone visit. Some clinics waive it if you start a protocol. Some do not charge it at all, which usually means it is folded into a higher medication markup.
Baseline labs. Bloodwork before anything is prescribed, not after. Depending on the panel, expect $150 to $450. A metabolic protocol needs a different panel than a growth hormone secretagogue protocol, so the lab cost varies with the goal. This is the line item most often skipped by low-cost telehealth operations, and skipping it is the reason to walk away.
The medication. The largest and most variable line. A compounded peptide filled by a licensed pharmacy might be $200 to $400 a month. A branded FDA-approved GLP-1 bought direct from the manufacturer sits in a different bracket entirely. Two patients at the same clinic can pay very different amounts here for legitimate reasons.
Follow-up and monitoring. Re-check labs, dose adjustments, and the visits where someone decides whether the protocol is working. Usually $100 to $250 per follow-up if billed separately, or included if you are on a program. Protocols without scheduled follow-up are cheaper because nobody is checking anything.
We price two ways, because two different things are being sold.
For metabolic and weight goals, the Medical Weight Loss program is $1,800 for six months. That is a single number covering the physician consultation, lab review, GLP-1 medication management, InBody body composition assessments and ongoing clinical support across the full protocol. It works out to $300 a month for supervised care, and it exists precisely because that category benefits from a fixed structure with a defined endpoint.
For everything else in peptide therapy, we quote after your consultation and baseline labs rather than before. This frustrates people who want a number on the phone, and we understand why. The reason we hold the line is that until a physician has seen your bloodwork, nobody can honestly say whether you need a three-month protocol or a twelve-month one, or whether a peptide is the right tool for your situation at all. A pre-consultation quote is a quote for a treatment plan that does not exist yet.
There is one more lever worth knowing about. Our membership program starts at $149 per month and carries 15 to 20 percent off all services, with the monthly credit rolling over and never expiring. For patients combining peptides with IV therapy, red light or hyperbaric sessions, the arithmetic often works out meaningfully in their favor. For someone doing one short protocol and nothing else, it usually does not, and we will say so.
The peptides most Miami patients are asking about are the metabolic ones: semaglutide and tirzepatide. These are FDA-approved drugs in their obesity-labeled forms, and their pricing has moved faster in the last two years than any other category in medicine.
As of 2026, the manufacturers sell direct to self-pay patients. Tirzepatide through LillyDirect and semaglutide through NovoCare Pharmacy sit in roughly the $200 to $450 per month band depending on dose and program tier, with introductory rates at the lower end for new patients. These figures change often enough that the only sensible instruction is to confirm current pricing with the manufacturer before you budget around it.
What this means practically is that the medication and the medical supervision have separated into two purchases. A clinic charging $1,200 a month for semaglutide therapy in 2026 is charging a large multiple over what the drug costs, and you are entitled to ask what the difference buys. At Nexsis the answer is the supervision, the labs, the composition tracking and the dose management, priced transparently as such.
Five things account for nearly all the variance between Miami quotes.
Which peptide. A growth hormone secretagogue like sermorelin or ipamorelin is a different cost structure from a GLP-1. A branded FDA-approved product is different again from a compounded preparation. Category drives price more than anything else.
The pharmacy. Licensed compounding pharmacies perform identity, purity and sterility testing, and that testing is priced into the vial. Vials sold online as research use only sit outside the pharmacy system entirely, which is exactly why they are cheaper and exactly why we do not use them. Sourcing is the single largest safety variable in peptide therapy.
Dose and titration. Most protocols start low and step up. Your month one cost is frequently not your month four cost, and a quote that does not acknowledge titration is an incomplete quote.
Protocol length. A twelve-week recovery protocol and an ongoing metabolic protocol are different financial commitments. Ask for the total, not the monthly.
How much monitoring is included. This is the line where cheap protocols get cheap. Fewer follow-ups and no repeat labs will always produce a lower headline price.
You do not need medical training to evaluate a peptide quote. You need four questions, and the quality of the answers tells you most of what you need to know.
Our clinical team, led by Dr. Alvaro J. Ocampo, Pathologist and Environmental Medicine Physician, answers all four in the consultation as a matter of course. We would rather you ask them of every Miami clinic you are considering, including ours.
Almost never, with one narrowing exception. Most peptide protocols are prescribed off-label or use compounded preparations, and neither is covered by US health insurers. The exception is FDA-approved GLP-1 medication for a documented obesity or type 2 diabetes indication, where some plans do cover the drug, though coverage has tightened considerably and prior authorization is the norm rather than the exception.
Practically, plan for peptide therapy as a self-pay treatment. HSA and FSA funds can often be applied when there is a legitimate medical indication and a physician prescription, which is worth raising with your plan administrator before you start. Baseline labs are sometimes billable to insurance even when the protocol is not, so ask.
Our clinic is at 40 SW 13th St in Brickell, and we see peptide patients from Coral Gables, Coconut Grove, Downtown Miami, Key Biscayne and Miami Beach. Miami pricing broadly tracks other major metros, though the concentration of concierge and longevity clinics in Brickell and Miami Beach means the top of the local range runs higher than the national average.
The wider spread in Miami is not primarily geographic. It is the difference between clinics that run labs and monitor protocols and clinics that ship vials after a five-minute video call. Those two things carry the same name and are not the same product, and the price gap between them is the most honest signal in the market.
If you want a real number for your situation, the path is a consultation and baseline labs, after which we can quote the actual protocol rather than a category average. If your goal is weight and metabolic health specifically, the six-month program at $1,800 is a fixed, known quantity you can decide on today.
Book a consultation with our Brickell physician team and we will tell you plainly what a protocol would cost, what it would involve, and whether a peptide is the right tool for what you are trying to change.
Most Miami patients pay $200 to $600 per month for the medication, with consultation and baseline labs adding $300 to $800 up front. At Nexsis BioHealth, the six-month medical weight loss program is $1,800 total, or $300 a month all in. Other protocols are quoted after labs because the drug and the protocol length drive the number.
Because the price depends on which peptide is prescribed, and that decision depends on your labs and your history. A phone quote is a quote for a protocol nobody has designed. Clinics that do quote flat rates before labs are usually selling a single product to everyone who calls.
It used to be significantly cheaper, and that gap has narrowed sharply now that manufacturers sell direct to self-pay patients at roughly $200 to $450 per month depending on dose and program. Compare the current direct price against any compounded quote before assuming compounded is the economical route. Manufacturer pricing changes frequently, so check it the week you decide.
Generally no. Off-label and compounded peptides are not covered by US insurers. FDA-approved GLP-1 medication for a documented obesity or diabetes indication is sometimes covered, usually with prior authorization. HSA and FSA funds can often be used where there is a legitimate medical indication.
No. Vials labeled research use only are sold outside the pharmacy system specifically so they can skip the identity, purity and sterility testing a licensed compounding pharmacy performs. You have no reliable way to know what is in the vial or at what concentration. The saving is real and the risk is the reason for it.
Yes, and any clinic willing to skip it is telling you something important about how it operates. Baseline labs establish candidacy, surface contraindications, and create the comparison point used later to judge whether the protocol is genuinely working rather than relying on how you feel in a given week.
